EML4 and cancer: We found that the promoter of EML4 was constitutively activated in lung cancer as well as normal cells independent of ALK fusion, and C-terminal ALK protein level and phosphorylation were specifically elevated in ALK fusion–positive cancer cells (Figs. 2 and 3b).